EARLI - Trademark Details![Image for trademark with serial number 88020634](/media/image.php?serial=88020634)
Status: 732 - Third Extension - Granted
Serial Number
88020634
Word Mark
EARLI
Status
732 - Third Extension - Granted
Status Date
2021-12-16
Filing Date
2018-06-29
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-01-14
Attorney Name
Law Office Assigned Location Code
O20
Employee Name
LEE, DOUGLAS M
Statements
Goods and Services
Assays, recombinant nucleic acid vectors, recombinant viral vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use
Goods and Services
Pharmaceutical and veterinary preparations and products for the prevention, detection, localization and treatment of cancer, infectious viral-based, bacterial-based, or fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart and vascular based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood based diseases, kidney, liver and pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, or toxic substances in the body tissue or fluids of humans and animals; Drug delivery agents in the form of compounds, tablet coatings, edible wafers, powders, tablets, and capsules, that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; reagents for use in therapeutics for medical purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, infectious viral-based, bacterial-based, or fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart and vascular based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood based diseases, kidney, liver and pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, or toxic substances in body tissue or fluids; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening or therapeutics purposes; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; assays, recombinant nucleic acid vectors, recombinant viral vectors, transfection agents, reagents, enzymes, and nucleotides for therapeutic purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, infectious viral-based, bacterial-based, or fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart and vascular based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood based diseases, kidney, liver and pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, or toxic substances in body tissue or fluids; therapeutic agents for medical diagnostic purposes and treatment of cancer, infectious viral-based, bacterial-based, or fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart and vascular based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood based diseases, kidney, liver and pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, or toxic substances in body tissue or fluids; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, infectious viral-based, bacterial-based, or fungal-based diseases, autoimmune diseases, allergies, respiratory diseases, heart and vascular based diseases, cerebrovascular disease, neurological disorders and diseases, metabolic diseases, genetic diseases, blood based diseases, kidney, liver and pancreatic diseases, muscular and neuromuscular diseases, gastrointestinal diseases and conditions, or toxic substances in body tissue or fluids
Goods and Services
Scientific apparatus in the nature of laboratory instruments for the detection and localization of diseases, pathogens, or toxic substances in humans and animals for laboratory or research use; scientific apparatus in the nature of laboratory instruments for the development of pharmaceuticals products or preparations for the prevention, detection, localization and treatment of diseases or pathogens or toxic substances in humans and animals
Goods and Services
Medical devices developed for the delivery of pharmaceuticals products or preparations and/or genetic material into human or animal tissues and/or cells for the purpose of diagnosis of disease or treatment of disease or pathogens or toxic substances in humans and animals; Medical devices developed for the delivery of pharmaceuticals products or preparations and/or genetic material into human or animal tissues and/or cells for the purpose of diagnosis of disease or treatment of disease or pathogens or toxic substances in humans and animals, namely, inhalers sold empty and drug delivery patches sold empty; medical laboratory instruments for treating infectious diseases or pathogens or toxic substances in humans and animals
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
005
International Class
009 - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus. - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
US Class Codes
021, 023, 026, 036, 038
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
009
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
010
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Connie L. Ellerbach
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0081632
Original Filing Date USPTO
2018-12-11
International Registration Number
1457028
International Registration Date
2018-12-11
International Status Code
480
International Renewal Date
2028-12-11
Madrid History Events | ||
Date | Code | Description |
2019-02-07 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
2019-03-21 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
2018-12-13 | MCERT | MANUALLY CERTIFIED |
2018-12-13 | APPST | IR CERTIFIED AND SENT TO IB |
2019-02-14 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
2019-02-14 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
2018-12-11 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2019-01-09 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
Trademark Events
Event Date | Event Description |
2018-07-03 | NEW APPLICATION ENTERED IN TRAM |
2018-07-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-10-22 | ASSIGNED TO EXAMINER |
2018-10-29 | NON-FINAL ACTION WRITTEN |
2018-10-29 | NON-FINAL ACTION E-MAILED |
2018-10-29 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-04-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-04-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-04-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-05-20 | FINAL REFUSAL WRITTEN |
2019-05-20 | FINAL REFUSAL E-MAILED |
2019-05-20 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2019-11-19 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2019-11-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-11-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-12-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-12-11 | ASSIGNED TO LIE |
2019-12-25 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-01-14 | PUBLISHED FOR OPPOSITION |
2020-01-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-02-13 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2020-06-04 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
2020-07-14 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-12-22 | TEAS EXTENSION RECEIVED |
2020-12-22 | EXTENSION 1 FILED |
2020-12-22 | EXTENSION 1 GRANTED |
2020-12-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-14 | TEAS EXTENSION RECEIVED |
2021-05-14 | EXTENSION 2 FILED |
2021-05-14 | EXTENSION 2 GRANTED |
2021-05-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-12-16 | TEAS EXTENSION RECEIVED |
2021-12-16 | EXTENSION 3 FILED |
2021-12-16 | EXTENSION 3 GRANTED |
2021-12-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |